Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2025-12-28 @ 8:49 PM
Study NCT ID:
NCT00419250
Status:
COMPLETED
Last Update Posted:
2019-11-08
First Post:
2007-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-05
First Submit QC Date:
None
Study First Post Date:
2007-01-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-08
Last Update Post Date Type:
ACTUAL